世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000037489

びまん性大細胞型B細胞リンパ腫治療薬の世界市場レポート(2024年)

The Business Research Company

Diffuse Large B-cell Lymphoma Therapeutics Global Market Report 2024

発刊日 2024/01/19

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000037489

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、びまん性大細胞型B細胞リンパ腫(DLBCL)治療薬の世界市場に関して、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。

本レポートは、力強い成長を遂げているびまん性大細胞型B細胞リンパ腫治療薬市場に焦点を当て、今後10年およびそれ以降の市場を形成するトレンドについてのガイドを提供します。

調査範囲

  • 調査市場
    ➣ 薬剤クラス別
      ◇ シスプラチン
      ◇ カルボプラチン
      ◇ 5-フルオロウラシル
      ◇ ドセタキセル
      ◇ パクリタキセル
      ◇ メトトレキサート
      ◇ その他
    ➣ 療法別
      ◇ 標的療法
      ◇ 免疫療法
      ◇ 化学療法
      ◇ その他
    ➣ 投与経路別
      ◇ 経口
      ◇ 非経口
      ◇ その他
    ➣ エンドユーザー別
      ◇ 病院
      ◇ クリニック
      ◇ その他
  • 調査企業
    ➣ Novartis AG
    ➣ Pfizer Inc.
    ➣ Merck & Co Inc.
    ➣ GlaxoSmithKline plc
    ➣ F. Hoffmann-La Roche AG
  • 調査国
    オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、イギリス、アメリカ、カナダ、イタリア、スペイン
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長率の関連市場に対する比率
    ➣ GDP比率
    ➣ 一人当たりの支出
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • 情報源および参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。
  • 提供形態
    ➣ PDF、Word、Excelデータダッシュボード

レポート詳細

目次

Table of Contents

1. Executive Summary

2. Diffuse Large B-cell Lymphoma Therapeutics Market Characteristics

3. Diffuse Large B-cell Lymphoma Therapeutics Market Trends And Strategies

4. Diffuse Large B-cell Lymphoma Therapeutics Market - Macro Economic Scenario
4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Diffuse Large B-cell Lymphoma Therapeutics Market Size and Growth
5.1. Global Diffuse Large B-cell Lymphoma Therapeutics Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Diffuse Large B-cell Lymphoma Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Diffuse Large B-cell Lymphoma Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Diffuse Large B-cell Lymphoma Therapeutics Market Segmentation
6.1. Global Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cisplatin
Carboplatin
5-fluorouracil
Docetaxel
Paclitaxel
Methotrexate
Other Drugs
6.2. Global Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Targeted Therapy
Immunotherapy
Chemotherapy
Other Therapies
6.3. Global Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Parenteral
Other Routes
6.4. Global Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Clinics
Other End-Users

7. Diffuse Large B-cell Lymphoma Therapeutics Market Regional And Country Analysis
7.1. Global Diffuse Large B-cell Lymphoma Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Diffuse Large B-cell Lymphoma Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Diffuse Large B-cell Lymphoma Therapeutics Market
8.1. Asia-Pacific Diffuse Large B-cell Lymphoma Therapeutics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Diffuse Large B-cell Lymphoma Therapeutics Market
9.1. China Diffuse Large B-cell Lymphoma Therapeutics Market Overview
9.2. China Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Diffuse Large B-cell Lymphoma Therapeutics Market
10.1. India Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Diffuse Large B-cell Lymphoma Therapeutics Market
11.1. Japan Diffuse Large B-cell Lymphoma Therapeutics Market Overview
11.2. Japan Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Diffuse Large B-cell Lymphoma Therapeutics Market
12.1. Australia Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Diffuse Large B-cell Lymphoma Therapeutics Market
13.1. Indonesia Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Diffuse Large B-cell Lymphoma Therapeutics Market
14.1. South Korea Diffuse Large B-cell Lymphoma Therapeutics Market Overview
14.2. South Korea Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Diffuse Large B-cell Lymphoma Therapeutics Market
15.1. Western Europe Diffuse Large B-cell Lymphoma Therapeutics Market Overview
15.2. Western Europe Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Diffuse Large B-cell Lymphoma Therapeutics Market
16.1. UK Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Diffuse Large B-cell Lymphoma Therapeutics Market
17.1. Germany Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Diffuse Large B-cell Lymphoma Therapeutics Market
18.1. France Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Diffuse Large B-cell Lymphoma Therapeutics Market
19.1. Italy Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Diffuse Large B-cell Lymphoma Therapeutics Market
20.1. Spain Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Diffuse Large B-cell Lymphoma Therapeutics Market
21.1. Eastern Europe Diffuse Large B-cell Lymphoma Therapeutics Market Overview
21.2. Eastern Europe Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Diffuse Large B-cell Lymphoma Therapeutics Market
22.1. Russia Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Diffuse Large B-cell Lymphoma Therapeutics Market
23.1. North America Diffuse Large B-cell Lymphoma Therapeutics Market Overview
23.2. North America Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Diffuse Large B-cell Lymphoma Therapeutics Market
24.1. USA Diffuse Large B-cell Lymphoma Therapeutics Market Overview
24.2. USA Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Diffuse Large B-cell Lymphoma Therapeutics Market
25.1. Canada Diffuse Large B-cell Lymphoma Therapeutics Market Overview
25.2. Canada Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Diffuse Large B-cell Lymphoma Therapeutics Market
26.1. South America Diffuse Large B-cell Lymphoma Therapeutics Market Overview
26.2. South America Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Diffuse Large B-cell Lymphoma Therapeutics Market
27.1. Brazil Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Diffuse Large B-cell Lymphoma Therapeutics Market
28.1. Middle East Diffuse Large B-cell Lymphoma Therapeutics Market Overview
28.2. Middle East Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Diffuse Large B-cell Lymphoma Therapeutics Market
29.1. Africa Diffuse Large B-cell Lymphoma Therapeutics Market Overview
29.2. Africa Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Diffuse Large B-cell Lymphoma Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Diffuse Large B-cell Lymphoma Therapeutics Market Competitive Landscape And Company Profiles
30.1. Diffuse Large B-cell Lymphoma Therapeutics Market Competitive Landscape
30.2. Diffuse Large B-cell Lymphoma Therapeutics Market Company Profiles
30.2.1. Novartis AG
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Pfizer Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Merck & Co Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. GlaxoSmithKline plc
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. F. Hoffmann-La Roche AG
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance

31. Global Diffuse Large B-cell Lymphoma Therapeutics Market Competitive Benchmarking

32. Global Diffuse Large B-cell Lymphoma Therapeutics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Diffuse Large B-cell Lymphoma Therapeutics Market

34. Diffuse Large B-cell Lymphoma Therapeutics Market Future Outlook and Potential Analysis
34.1 Diffuse Large B-cell Lymphoma Therapeutics Market In 2028 - Countries Offering Most New Opportunities
34.2 Diffuse Large B-cell Lymphoma Therapeutics Market In 2028 - Segments Offering Most New Opportunities
34.3 Diffuse Large B-cell Lymphoma Therapeutics Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies

35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer

この商品のレポートナンバー

0000037489

TOP